Analystreport

Iterum Therapeutics PLC (NASDAQ: ITRM) was downgraded by analysts at Gabelli from a "buy" rating to a "sell" rating.

Iterum Therapeutics plc - Ordinary Share  (ITRM) 
Last iterum therapeutics plc - ordinary share earnings: 11/12 04:30 pm Check Earnings Report